NASDAQ:LFCR

Lifecore Biomedical - LFCR Stock Forecast, Price & News

$3.10

+1.43 (+85.63%)

(As of 03/20/2023 12:00 AM ET)

Add

Compare

Today's Range: $1.80
▼
$3.14
50-Day Range: $1.67
▼
$7.26
52-Week Range: $1.52
▼
$11.96

Volume: 31.58 million shs
Average Volume: 788,635 shs
Market Capitalization: $91.76 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $9.50

Lifecore Biomedical MarketRank™ Forecast

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 206.5% Upside
$9.50 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.14
Based on 19 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.29) to $0.05 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.81 out of 5 stars

Medical Sector

787th out of 988 stocks

Pharmaceutical Preparations Industry

378th out of 482 stocks

3.0

Analyst's Opinion

Consensus Rating
Lifecore Biomedical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $9.50, Lifecore Biomedical has a forecasted upside of 206.5% from its current price of $3.10.
Amount of Analyst Coverage
Lifecore Biomedical has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for LFCR.

0.0

Dividend Strength

Dividend Yield
Lifecore Biomedical does not currently pay a dividend.
Dividend Growth
Lifecore Biomedical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for LFCR.

2.1

News and Social Media Coverage

News Sentiment
Lifecore Biomedical has a news sentiment score of -0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.35 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 19 news articles for Lifecore Biomedical this week, compared to 1 article on an average week.
Search Interest
23 people have searched for LFCR on MarketBeat in the last 30 days. This is an increase of 5% compared to the previous 30 days.
MarketBeat Follows
4 people have added Lifecore Biomedical to their MarketBeat watchlist in the last 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Lifecore Biomedical insiders have not sold or bought any company stock.
Percentage Held by Insiders
14.61% of the stock of Lifecore Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Lifecore Biomedical are expected to grow in the coming year, from ($0.29) to $0.05 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Lifecore Biomedical is -1.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Lifecore Biomedical is -1.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Lifecore Biomedical has a P/B Ratio of 0.85. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Lifecore Biomedical (NASDAQ:LFCR) Stock

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. It operates through the following segments: Lifecore, Curation Foods, and Others. The Lifecore segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans. The Curation Foods segment includes activities to market and pack specialty packaged whole and fresh-cut fruit and vegetables. The Other segment consists of corporate general and administrative expenses, non-Curation Foods and non-Lifecore interest income, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Santa Maria, CA.

Receive LFCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter.

LFCR Stock News Headlines

March 20, 2023 | msn.com

Lifecore Biomedical, Inc. - Common Stock's Return On Capital Employed Insights

March 20, 2023 | americanbankingnews.com

Lifecore Biomedical (NASDAQ:LFCR) Rating Lowered to Equal Weight at Stephens

March 21, 2023 | Behind the Markets (Ad)

BREAKING: Tiny biotech successfully treats blindness

There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.

March 20, 2023 | americanbankingnews.com

Stephens Reaffirms Overweight Rating for Lifecore Biomedical (NASDAQ:LFCR)

March 18, 2023 | finance.yahoo.com

Q2 2023 Lifecore Biomedical Inc Earnings Call

March 17, 2023 | seekingalpha.com

Lifecore craters ~60% on 'substantial doubt' as going concern; explores options amid Q2 miss

March 16, 2023 | msn.com

Lifecore Biomedical Non-GAAP EPS of -$0.24 misses by $0.20, revenue of $38.8M misses by $9.61M

March 16, 2023 | finance.yahoo.com

Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results

March 21, 2023 | Behind the Markets (Ad)

BREAKING: Tiny biotech successfully treats blindness

March 16, 2023 | finance.yahoo.com

Lifecore Biomedical Announces Intent to Explore Strategic Alternatives

March 16, 2023 | finance.yahoo.com

Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship

March 14, 2023 | americanbankingnews.com

Critical Review: Lifecore Biomedical (LFCR) vs. Its Competitors

February 16, 2023 | finance.yahoo.com

Should You Invest in Lifecore Biomedical (LFCR)?

February 7, 2023 | finance.yahoo.com

Lifecore Biomedical Announces Sale of Curation Foods’ Avocado Products Business

February 2, 2023 | msn.com

Lifecore Biomedical to restate financials after finding errors

January 28, 2023 | seekingalpha.com

LFCR Lifecore Biomedical, Inc.

January 12, 2023 | finance.yahoo.com

Should You Hold Lifecore Biomedical (LFCR)?

January 11, 2023 | finance.yahoo.com

Lifecore Biomedical Receives Notice from Nasdaq Regarding Delayed Quarterly Report

January 9, 2023 | finance.yahoo.com

Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities

December 28, 2022 | finance.yahoo.com

Investors in Lifecore Biomedical (NASDAQ:LFCR) have unfortunately lost 47% over the last five years

December 8, 2022 | finance.yahoo.com

Lifecore Biomedical, Inc. (NASDAQ:LFCR): Are Analysts Optimistic?

November 30, 2022 | msn.com

$5 Million Bet On Lifecore Biomedical? Check Out These 4 Stocks Insiders Are Buying

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive LFCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter.

LFCR Company Calendar

Today: 3/20/2023
Next Earnings (Estimated): 4/04/2023
Fiscal Year End: 5/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:LFCR
CUSIP: N/A
CIK: 1005286
Web: www.lifecore.com
Phone: (800) 454-1355
Fax: 650-368-9818
Employees: N/A
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $9.50
High Stock Price Forecast: $11.00
Low Stock Price Forecast: $8.00
Forecasted Upside/Downside: +206.5%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.50)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-97,430,000.00
Net Margins: -36.49%
Pretax Margin: -20.04%
Return on Equity: -16.79%
Return on Assets: -6.38%

Debt

Debt-to-Equity Ratio: 0.99
Current Ratio: 1.40
Quick Ratio: 0.63

Sales & Book Value

Annual Sales: $185.79 million
Price / Sales: 0.49
Cash Flow: $6.60 per share
Price / Cash Flow: 0.47
Book Value: $3.66 per share
Price / Book: 0.85

Miscellaneous

Outstanding Shares: 29,600,000
Free Float: 25,272,000
Market Cap: $91.76 million
Optionable: Optionable
Beta: 1.11

Key Executives

James G. Hall
President, Chief Executive Officer & Director

John D. Morberg
CFO, Secretary & Chief Accounting Officer

Key Competitors

View All Competitors

LFCR Stock - Frequently Asked Questions

Should I buy or sell Lifecore Biomedical stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lifecore Biomedical in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" LFCR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LFCR, but not buy additional shares or sell existing shares.
View LFCR analyst ratings or view top-rated stocks.
What is Lifecore Biomedical's stock price forecast for 2023?: 1 Wall Street research analysts have issued 12 month price targets for Lifecore Biomedical's stock. Their LFCR share price forecasts range from $8.00 to $11.00. On average, they predict the company's share price to reach $9.50 in the next twelve months. This suggests a possible upside of 206.5% from the stock's current price.
View analysts price targets for LFCR or view top-rated stocks among Wall Street analysts.
How have LFCR shares performed in 2023?: Lifecore Biomedical's stock was trading at $6.48 at the start of the year. Since then, LFCR stock has decreased by 52.2% and is now trading at $3.10.
View the best growth stocks for 2023 here.
When is Lifecore Biomedical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 4th 2023.
View our LFCR earnings forecast.

What is Lifecore Biomedical's stock symbol?: Lifecore Biomedical trades on the NASDAQ under the ticker symbol "LFCR."
How do I buy shares of Lifecore Biomedical?: Shares of LFCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Lifecore Biomedical's stock price today?: One share of LFCR stock can currently be purchased for approximately $3.10.
How much money does Lifecore Biomedical make?: Lifecore Biomedical (NASDAQ:LFCR) has a market capitalization of $91.76 million and generates $185.79 million in revenue each year. The company earns $-97,430,000.00 in net income (profit) each year or ($2.50) on an earnings per share basis.
How can I contact Lifecore Biomedical?: Lifecore Biomedical's mailing address is 2811 AIRPARK DRIVE, SANTA MARIA CA, 93455. The official website for the company is www.lifecore.com. The company can be reached via phone at (800) 454-1355, via email at jeff.sonnek@icrinc.com, or via fax at 650-368-9818.

This page (NASDAQ:LFCR) was last updated on 3/21/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Lifecore Biomedical - LFCR Stock Forecast, Price & News

Lifecore Biomedical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Lifecore Biomedical (NASDAQ:LFCR) Stock

LFCR Stock News Headlines

LFCR Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

LFCR Stock - Frequently Asked Questions

Overall MarketRank^™